# Trade Mark Journal No.2025/040 3 October 2025

## WO0000001875987 (5,44)

Office of origin: United States of America

Date of International Registration:18 August 2025
Date of designation in the UK: 18 August 2025

International priority date claimed: 25 February 2025 (United States of America) (99055263)

Class 5
  Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of fibrotic disorders.
Class 44
  Providing medical information via a website.

INCYTE HOLDINGS CORPORATION

Representative: Frances M. Jagla Christensen O'Connor Johnson Kindness, 1201 Third Avenue, Suite 3600, Seattle WA 98101, UNITED STATES OF AMERICA